James Wheless News Today

Terrence is a Memphis teen battling tuberous sclerosis complex, a rare disease that causes tumors throughout the body.

CORAL GABLES, Fla., Aug. 14, 2023 -- Catalyst Pharmaceuticals, Inc. , a commercial-stage, patient-centric biopharmaceutical company focused on in-licensing, developing and commercializing novel... -Today at 08:06 am- MarketScreener

Beat.com.au - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from beat.com.au Daily Mail and Mail on Sunday newspapers.

James Wheless, professor and chief of the Department of Pediatric Neurology at the University of Tennessee Health Science Center, gave lectures earlier this month at Korean hospitals on vagus nerve stimulation (VNS), a technique for treating people with epilepsy.

New device expands access to the latest technology for legacy VNS Therapy patients with drug-resistant epilepsy in the U.S. LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology and innovation

02.02.2023 - LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology and innovation company, today launched SenTiva DUO, an implantable pulse generator (IPG) with a dual-pin header to provide VNS Therapy for the treatment of drug-resistant epilepsy. The ... Seite 1

/PRNewswire/ -- Neurelis, Inc., announced the company will present nine posters at the 76th American Epilepsy Society Annual Meeting (AES), December 2 – 6,...

Through collaborations with Le Bonheur Childrens Hospital, the Wisconsin Health Information Organization, and Yale University, UCB seeks to further understand...

UCB today announced three collaborations aimed at examining the impact of seizure clusters on patient and caregiver quality of life.